Digestives & Intestinal Remedies - Ireland

In Ireland, the revenue generated in the Digestives & Intestinal Remedies market market in 2024 amounts to US$25.86m.
It is projected to experience an annual growth rate of 2.05% (CAGR 2024-2029).
When comparing this to the global market, China leads the way with a revenue of US$4.41bn in 2024.
In terms of per person revenues, in Ireland generates US$5.08 in 2024.
Ireland's Digestives & Intestinal Remedies market is seeing a surge in demand for natural and herbal remedies.

Definition:
The Digestives and Intestinal Remedies market comprises over-the-counter natural and synthetic digestive agents and remedies against gastrointestinal complaints. Digestives include preparations in the form of pills, powder, capsules, liquids, solutions, suspensions, drops and suppositories. Not included are prescription medicines, preparations that are against the state law or are not explicit digestive drugs (e.g. painkillers). Among the top-selling digestives are Perenterol, Iberogast, Dulcolax and Buscopan Plus. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestives & Intestinal Remedies market in Ireland is experiencing steady growth due to changing customer preferences, market trends, local special circumstances, and underlying macroeconomic factors.Customer preferences in the Digestives & Intestinal Remedies market in Ireland are shifting towards natural and organic products. Consumers are becoming more health-conscious and are seeking products that are free from artificial ingredients and chemicals. This preference for natural remedies is driving the demand for herbal and plant-based digestive and intestinal remedies in the market.Trends in the Digestives & Intestinal Remedies market in Ireland are influenced by global and regional market trends. One of the key trends is the rising incidence of digestive disorders and gastrointestinal issues. Factors such as poor diet, sedentary lifestyle, and stress contribute to the prevalence of these conditions, leading to an increased demand for digestive and intestinal remedies.Another trend in the market is the growing popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for gut health. They help restore the natural balance of bacteria in the digestive system and promote overall digestive health. The increasing awareness of the importance of gut health and the benefits of probiotics are driving the demand for probiotic-based digestive and intestinal remedies in Ireland.Local special circumstances in Ireland also contribute to the development of the Digestives & Intestinal Remedies market. The Irish population has a high consumption of dairy products, which can lead to lactose intolerance and other digestive issues. This creates a demand for lactose-free and dairy-free digestive remedies in the market.Underlying macroeconomic factors such as increasing disposable income and healthcare expenditure are also driving the growth of the Digestives & Intestinal Remedies market in Ireland. As people have more disposable income, they are willing to spend on healthcare products and remedies to maintain their overall well-being. The government's focus on healthcare and wellness initiatives also plays a role in driving the market growth.In conclusion, the Digestives & Intestinal Remedies market in Ireland is developing due to changing customer preferences towards natural and organic products, trends such as the rising incidence of digestive disorders and the popularity of probiotics, local special circumstances like high dairy consumption, and underlying macroeconomic factors such as increasing disposable income and healthcare expenditure.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.